(Q48459103)

11 February 2018

editorial

0 references

title

Haralampos M. Moutsopoulos: A lifetime in autoimmunity (English)

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

14 June 2024

1

Pierre Youinou

1 reference

11 February 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20673706

14 June 2024

publication date

31 July 2010

1 reference

11 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0896841110000582?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

https://api.elsevier.com/content/article/PII:S0896841110000582?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

14 June 2024

published in

Journal of Autoimmunity

1 reference

11 February 2018

volume

35

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

171-175

1 reference

11 February 2018

Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Navigating the passage between Charybdis and Scylla: recognizing the achievements of Noel Rose

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoimmune disease after autologous hematopoietic stem cell transplantation

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Environmental triggers of autoimmune thyroiditis

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Sjögren syndrome: advances in the pathogenesis from animal models

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Novel molecular targets in the treatment of systemic lupus erythematosus

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Role of Th1 and Th17 cells in organ-specific autoimmunity.

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Systemic lupus erythematosus and "lupus dyslipoproteinemia".

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Preventive strategies in systemic lupus erythematosus.

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Alternatively activated macrophages in infection and autoimmunity

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

GAD65 as a prototypic autoantigen

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoimmunity and persistent viral infection: Two sides of the same coin?

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The mosaic of autoimmunity

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

In vivo bioimaging using photogenic rats: fate of injected bone marrow-derived mesenchymal stromal cells

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Type 1 diabetes: lessons for other autoimmune diseases?

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Extrathymic mechanisms of T cell tolerance: lessons from autoimmune gastritis

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The genetics of human autoimmune disease

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Prolactin, dendritic cells, and systemic lupus erythematosus

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The genetics of immunoregulatory T cells

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function.

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoimmune myocarditis: past, present and future

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Genetic complexity of autoimmune myocarditis

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Clustering and commonalities among autoimmune diseases

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Will hematopoietic stem cell transplantation cure human autoimmune diseases?

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Preventing autoimmune and infection triggered atherosclerosis for an enduring healthful lifestyle

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Systems genetics can provide new insights in to immune regulation and autoimmunity.

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Cell and gene therapy using mesenchymal stem cells (MSCs).

14 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Hunt for pluripotent stem cell -- regenerative medicine search for almighty cell

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Systemic lupus erythematosus in the elderly

14 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Application of tissue-specific NK and NKT cell activity for tumor immunotherapy

14 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

A tribute to an outstanding immunologist - Ian Reay Mackay

14 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The immunobiology of Henoch-Schönlein purpura.

14 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Consideration of strategies for hematopoietic cell transplantation.

14 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations

14 June 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Asymptomatic diffuse fasciitis with eosinophilia

14 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients

14 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients

14 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoantibody profiles in the sera of European patients with myositis

14 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Prevalence of Sjögren's syndrome in a closed rural community

14 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome

14 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study

14 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study

14 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome.

14 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Association of Sjögren's syndrome with HLA-B8.

14 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression

14 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy

14 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient

14 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen

14 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis

14 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement

14 June 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome

14 June 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Salivary gland epithelial cell exosomes: A source of autoantigenic ribonucleoproteins

14 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Stress, coping strategies and social support in patients with primary Sjögren's syndrome prior to disease onset: a retrospective case-control study

14 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Immunization of patients with Sjögren's syndrome with pneumococcal polysaccharide vaccine: a randomized trial

14 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Thyroid disease in Sjögren's syndrome

14 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Familial Mediterranean fever associated pyrin mutations in Greece

14 June 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome

14 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members

14 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: Correlation with certain features of immune hyperactivity and factors associated

14 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome

14 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome

14 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Impaired elastic properties of ascending aorta in patients with giant cell arteritis

14 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Lupus nephritis: current issues

14 June 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The geoepidemiology of Sjögren's syndrome

14 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides

14 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Selective renal angiography in Wegener's granulomatosis

14 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome

14 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Herpes zoster in patients with systemic lupus erythematosus

14 June 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance

14 June 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

HLA-DR expression by labial minor salivary gland tissues in Sjögren's syndrome

14 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Correlative histologic and serologic findings of sicca syndrome in patients with systemic lupus erythematosus

14 June 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects

14 June 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Inability of peripheral blood leukocytes from systemic lupus erythematosus patients to produce interferons in vitro

14 June 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands

14 June 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Pulmonary capillary endothelial dysfunction in early systemic sclerosis

14 June 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Slow viruses and the immune system in the pathogenesis of local tissue damage in Sjogren's syndrome

14 June 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease

14 June 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Determinants of pulmonary arterial hypertension in scleroderma

14 June 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline

14 June 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Sicca-like syndrome in type V hyperlipoproteinemia

14 June 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Non-isotopic RNase cleavage assay for mutation detection in MEFV, the gene responsible for familial Mediterranean fever, in a cohort of Greek patients

14 June 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.

14 June 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Middle ear function in patients with juvenile chronic arthritis

14 June 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Outcome of pregnancy in patients with autoimmune rheumatic disease before the disease onset

14 June 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Primary amyloidosis resembling sicca syndrome

14 June 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome.

14 June 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Obstetric and gynaecological profile in patients with primary Sjögren's syndrome

14 June 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Central nervous system involvement in Sjogren's syndrome

14 June 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring

14 June 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Lymphoma development in Sjögren's syndrome: novel p53 mutations

14 June 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Characterization of the cysteine-rich secretory protein 3 gene as an early-transcribed gene with a putative role in the pathophysiology of Sjögren's syndrome

14 June 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases

14 June 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome

14 June 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.

14 June 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging

14 June 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.

14 June 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Evidence for coxsackievirus infection in primary Sjögren's syndrome

14 June 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Oesophageal dysfunction in patients with primary Sjögren's syndrome

14 June 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Sialochemistry of patients with autoimmune rheumatic disease with and without histological manifestations of Sjögren's syndrome

14 June 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Thoracoabdominal motion in ankylosing spondylitis: association with standardised clinical measures and response to therapy

14 June 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study

14 June 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome

14 June 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Autoantibodies to HMG-17 nucleosomal protein in autoimmune rheumatic diseases. Correlation with systemic lupus erythematosus clinical activity and with antibodies to double-stranded DNA

14 June 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome

14 June 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease

14 June 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.

14 June 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

14 June 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

14 June 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

14 June 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome

14 June 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome

14 June 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.

14 June 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis

14 June 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome

14 June 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).

14 June 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin

14 June 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

2-chloro-2'-deoxyadenosine in the treatment of Sjögren's syndrome-associated B cell lymphoproliferation

14 June 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

Monoclonal expansion of B cells in Sjögren's syndrome: comment on the article by Martin et al

14 June 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation

14 June 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.JAUT.2010.06.003

14 June 2024

Identifiers

1 reference

11 February 2018

1 reference

11 February 2018